Myostatin signaling regulates Akt activity via the regulation of miR-486 expression

International Journal of Biochemistry and Cell Biology

Volumn 47, Issue 1, 2014, Pages 93-103

  Hitachi, Keisuke ^a   Nakatani, Masashi ^a   Tsuchida, Kunihiro ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Akt; Ank1.5; miR 486; Myostatin; Smad3

Indexed keywords

ANKYRIN; DICER; ENDONUCLEASE; LUCIFERASE; MICRORNA; MICRORNA 486; MYOD PROTEIN; MYOSTATIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE B; RIBONUCLEASE III; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; E BOX ELEMENT; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AKT; ANK1.5; MIR-486; MYOSTATIN; SMAD3;

ANIMALS; ANKYRINS; CELL LINE; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MICRORNAS; MUSCLE, SKELETAL; MYOSTATIN; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSFECTION;

EID: 84891538950     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.12.003     Document Type: Article

References (57)

1. M.S. Alexander, J.C. Casar, N. Motohashi, J.A. Myers, I. Eisenberg, and R.T. Gonzalez et al. Regulation of DMD pathology by an ankyrin-encoded miRNA Skeletal Muscle 1 2011 27
2. A. Amirouche, A.-C. Durieux, S. Banzet, N. Koulmann, R. Bonnefoy, and C. Mouret et al. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle Endocrinology 150 1 2009 286 294
3. C. Anderson, H. Catoe, and R. Werner MIR-206 regulates connexin43 expression during skeletal muscle development Nucleic Acids Res 34 20 2006 5863 5871 (Pubitemid 44941165)
4. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2 2009 215 233
5. I. Chelh, B. Meunier, B. Picard, M.J. Reecy, C. Chevalier, and J.-F. Hocquette et al. Molecular profiles of quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets BMC Genomics 10 2009 196
6. J-F. Chen, Y. Tao, J. Li, Z. Deng, Z. Yan, and X. Xiao et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7 J Cell Biol 190 5 2010 867 879
7. A. Clop, F. Marcq, H. Takeda, D. Pirottin, X. Tordoir, and B. Bibé et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep Nat Genet 38 7 2006 813 818 (Pubitemid 43980603)
8. P. Costelli, M. Muscaritoli, A. Bonetto, F. Penna, P. Reffo, and M. Bossola et al. Muscle myostatin signalling is enhanced in experimental cancer cachexia Eur J Clin Invest 38 7 2008 531 538 (Pubitemid 351832040)
9. B.K. Dey, J. Gagan, and A. Dutta miR-206 and -486 induce myoblast differentiation by downregulating Pax7 Mol Cell Biol 31 1 2011 203 214
10. D.J. Glass PI3 kinase regulation of skeletal muscle hypertrophy and atrophy Curr Top Microbiol Immunol 346 2010 267 278
11. N.F. Gonzalez-Cadavid, W.E. Taylor, K. Yarasheski, I. Sinha-Hikim, K. Ma, and S. Ezzat et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting Proc Natl Acad Sci USA 95 25 1998 14938 14943 (Pubitemid 29003735)
12. L. Grobet, L.J. Martin, D. Poncelet, D. Pirottin, B. Brouwers, and J. Riquet et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle Nat Genet 17 1 1997 71 74 (Pubitemid 27377534)
13. I. Güller, and A.P. Russell MicroRNAs in skeletal muscle: their role and regulation in development, disease and function J Physiol (Lond) 588 Pt 21 2010 4075 4087
14. D.L. Hamilton, A. Philp, M.G. MacKenzie, and K. Baar A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise PLoS ONE 5 7 2010 e11624
15. S. Kalista, O. Schakman, H. Gilson, P. Lause, B. Demeulder, and L. Bertrand et al. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy Endocrinology 153 1 2012 241 253
16. B. Langley, M. Thomas, A. Bishop, M. Sharma, S. Gilmour, and R. Kambadur Myostatin inhibits myoblast differentiation by down-regulating MyoD expression J Biol Chem 277 51 2002 49831 49840 (Pubitemid 36014431)
17. S.-J. Lee Regulation of muscle mass by myostatin Annu Rev Cell Dev Biol 20 2004 61 86 (Pubitemid 39488633)
18. S.-J. Lee, T.V. Huynh, Y.-S. Lee, S.M. Sebald, S.A. Wilcox-Adelman, and N. Iwamori et al. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway Proc Natl Acad Sci USA 109 35 2012 E2353 E2360
19. S.-J. Lee, and A.C. McPherron Regulation of myostatin activity and muscle growth Proc Natl Acad Sci USA 98 16 2001 9306 9311 (Pubitemid 32743912)
20. C. Lipina, H. Kendall, A.C. McPherron, P.M. Taylor, and H.S. Hundal Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice FEBS Lett 584 11 2010 2403 2408
21. D. Liu, B.L. Black, and R. Derynck TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 Genes Dev 15 22 2001 2950 2966 (Pubitemid 33078946)
22. N. Liu, A.H. Williams, J.M. Maxeiner, S. Bezprozvannaya, J.M. Shelton, and J.A. Richardson et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice J Clin Invest 122 6 2012 2054 2065
23. C. McFarlane, E. Plummer, M. Thomas, A. Hennebry, M. Ashby, and N. Ling et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism J Cell Physiol 209 2 2006 501 514 (Pubitemid 44484641)
24. A.C. McPherron, A.M. Lawler, and S.-J. Lee Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 6628 1997 83 90 (Pubitemid 27202654)
25. A.C. McPherron, and S.-J. Lee Double muscling in cattle due to mutations in the myostatin gene Proc Natl Acad Sci USA 94 23 1997 12457 12461 (Pubitemid 27492550)
26. M.R. Morissette, S.A. Cook, C. Buranasombati, M.A. Rosenberg, and A. Rosenzweig Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt Am J Physiol Cell Physiol 297 5 2009 C1124 C1132
27. D.S. Mosher, P. Quignon, C.D. Bustamante, N.B. Sutter, C.S. Mellersh, and H.G. Parker et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs PLoS Genetics 3 5 2007 e79
28. M. Nakatani, Y. Takehara, H. Sugino, M. Matsumoto, O. Hashimoto, and Y. Hasegawa et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice FASEB J 22 2 2008 477 487 (Pubitemid 351225584)
29. J.R. O'Rourke, S.A. Georges, H.R. Seay, S.J. Tapscott, M.T. McManus, and D.J. Goldhamer et al. Essential role for Dicer during skeletal muscle development Dev Biol 311 2 2007 359 368 (Pubitemid 350046531)
30. S. Rachagani, Y. Cheng, and J.M. Reecy Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle BMC Res Notes 3 2010 297
31. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, and T.N. Stitt et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat Cell Biol 3 11 2001 1009 1013 (Pubitemid 34428746)
32. R. Sartori, G. Milan, M. Patron, C. Mammucari, B. Blaauw, and R. Abraham et al. Smad2 and 3 transcription factors control muscle mass in adulthood Am J Physiol Cell Physiol 296 6 2009 C1248 C1257
33. R. Sartori, E. Schirwis, B. Blaauw, S. Bortolanza, J. Zhao, and E. Enzo et al. BMP signaling controls muscle mass Nat Genet 45 11 2013 1309 1318
34. D. Sayed, and M. Abdellatif MicroRNAs in development and disease Physiol Rev 91 3 2011 827 887
35. S. Schiaffino, K.A. Dyar, S. Ciciliot, B. Blaauw, and M. Sandri Mechanisms regulating skeletal muscle growth and atrophy FEBS J 280 17 2013 4294 4314
36. S. Schiaffino, and C. Mammucari Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models Skeletal Muscle 1 1 2011 4
37. M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hübner, T. Riebel, and W. Kömen et al. Myostatin mutation associated with gross muscle hypertrophy in a child N Engl J Med 350 26 2004 2682 2688 (Pubitemid 38788003)
38. A.P. Sharples, N. Al-Shanti, D.C. Hughes, M.P. Lewis, and C.E. Stewart The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy Growth Horm IGF Res 23 3 2013 53 61
39. K.G. Shyu, M.J. Lu, B.W. Wang, H.Y. Sun, and H. Chang Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure Eur J Clin Invest 36 10 2006 713 719 (Pubitemid 44393930)
40. H. Siomi, and M.C. Siomi Posttranscriptional regulation of microRNA biogenesis in animals Mol Cell 38 3 2010 323 332
41. E.M. Small, J.R. O'Rourke, V. Moresi, L.B. Sutherland, J. McAnally, and R.D. Gerard et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486 Proc Natl Acad Sci USA 107 9 2010 4218 4223
42. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, and T. Sasaki et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1 1998 29 39 (Pubitemid 28458022)
43. W.E. Taylor, S. Bhasin, J. Artaza, F. Byhower, M. Azam, and D.H. Willard et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells Am J Physiol Endocrinol Metab 280 2 2001 E221 E228
44. A.U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D.J. Glass Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size Am J Physiol Cell Physiol 296 6 2009 C1258 C1270
45. K. Tsuchida, M. Nakatani, A. Uezumi, T. Murakami, and X. Cui Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer Endocr J 55 1 2008 11 21 (Pubitemid 351520175)
46. S. Welle, K. Bhatt, and C.A. Pinkert Myofibrillar protein synthesis in myostatin-deficient mice Am J Physiol Endocrinol Metab 290 3 2006 E409 E415
47. S. Welle, K. Burgess, and S. Mehta Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice Am J Physiol Endocrinol Metab 296 3 2009 E567 E572
48. S. Welle, S. Mehta, and K. Burgess Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism Am J Physiol Endocrinol Metab 300 6 2011 E993 E1001
49. A.H. Williams, G. Valdez, V. Moresi, X. Qi, J. McAnally, and J.L. Elliott et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice Science 326 5959 2009 1549 1554
50. N.G. Williams, J.P. Interlichia, M.F. Jackson, D. Hwang, P. Cohen, and B.D. Rodgers Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis Endocrinology 152 1 2011 172 180
51. C.E. Winbanks, C. Beyer, A. Hagg, H. Qian, P.V. Sepulveda, and P. Gregorevic miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4 PLoS ONE 8 9 2013 e73589
52. C.E. Winbanks, J.L. Chen, H. Qian, Y. Liu, B.C. Bernardo, and C. Beyer et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass J Cell Biol 203 2 2013 345 357
53. C.E. Winbanks, K.L. Weeks, R.E. Thomson, P.V. Sepulveda, C. Beyer, and H. Qian et al. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin J Cell Biol 197 7 2012 997 1008
54. J.A. Wolff, R.W. Malone, P. Williams, W. Chong, G. Acsadi, and A. Jani et al. Direct gene transfer into mouse muscle in vivo Science 247 4949 Pt 1 1990 1465 1468
55. J. Xu, R. Li, B. Workeneh, Y. Dong, X. Wang, and Z. Hu Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486 Kidney Int 82 4 2012 401 411
56. K.E. Yarasheski, S. Bhasin, I. Sinha-Hikim, J. Pak-Loduca, and N.F. Gonzalez-Cadavid Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting J Nutr Health Aging 6 5 2002 343 348 (Pubitemid 36118984)
57. T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, and K.N. Tomkinson et al. Induction of cachexia in mice by systemically administered myostatin Science 296 5572 2002 1486 1488 (Pubitemid 34553097)